6.58
price up icon3.30%   0.21
 
loading

Personalis Inc (PSNL) 最新ニュース

pulisher
Jun 18, 2025

The 13% return this week takes Personalis' (NASDAQ:PSNL) shareholders one-year gains to 394% - Yahoo

Jun 18, 2025
pulisher
Jun 17, 2025

Personalis (PSNL) Soars 7.3%: Is Further Upside Left in the Stock? - Yahoo Finance

Jun 17, 2025
pulisher
Jun 09, 2025

Personalis, Inc. (NASDAQ:PSNL) Receives Consensus Rating of “Buy” from Brokerages - Defense World

Jun 09, 2025
pulisher
Jun 08, 2025

Personalis: Ultra-Sensitive Tech, Ultra-Sensitive Risks (NASDAQ:PSNL) - Seeking Alpha

Jun 08, 2025
pulisher
Jun 08, 2025

Two Sigma Advisers LP Grows Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Jun 08, 2025
pulisher
Jun 07, 2025

Personalis, Inc. (NASDAQ:PSNL) Shares Purchased by Two Sigma Investments LP - Defense World

Jun 07, 2025
pulisher
Jun 07, 2025

Ameriprise Financial Inc. Has $199,000 Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Jun 07, 2025
pulisher
Jun 06, 2025

Bank of America Corp DE Sells 30,474 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World

Jun 06, 2025
pulisher
Jun 04, 2025

Personalis, Inc. (PSNL) ctDNA Test Predicts TNBC Relapse Risk Post-Therapy - MSN

Jun 04, 2025
pulisher
Jun 04, 2025

Personalis’ NeXT Personal® Predicts Cervical Cancer Recurrence Risk in New CALLA Phase 3 Study Analysis Presented at ASCO - BioSpace

Jun 04, 2025
pulisher
Jun 04, 2025

Personalis reveals ctDNA test predicts cervical cancer relapse By Investing.com - Investing.com South Africa

Jun 04, 2025
pulisher
Jun 03, 2025

Personalis reveals ctDNA test predicts cervical cancer relapse - Investing.com Australia

Jun 03, 2025
pulisher
Jun 03, 2025

Personalis (PSNL) Blood Test Shows Promise in Detecting Cervical Cancer Early | PSNL Stock News - GuruFocus

Jun 03, 2025
pulisher
Jun 02, 2025

Personalis Says Studies Show NeXT Personal Test Could Identify Relapse Risk in Breast Cancer Patients - marketscreener.com

Jun 02, 2025
pulisher
Jun 02, 2025

Personalis (PSNL) Showcases Promising Results for NeXT Personal in Breast Cancer Care | PSNL Stock News - GuruFocus

Jun 02, 2025
pulisher
Jun 02, 2025

New Data Shows NeXT Personal® Identifies Breast Cancer Patients Receiving Neoadjuvant Therapy that are at High Risk for Relapse - Yahoo Finance

Jun 02, 2025
pulisher
Jun 01, 2025

Northern Trust Corp Lowers Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

Jun 01, 2025
pulisher
May 27, 2025

Millennium Management LLC Has $7.61 Million Stock Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 27, 2025
pulisher
May 26, 2025

BNP Paribas Financial Markets Acquires 71,721 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 26, 2025
pulisher
May 22, 2025

Personalis and Academic Partners to Present Latest Data on Ultra - GuruFocus

May 22, 2025
pulisher
May 22, 2025

Personalis and Academic Partners to Present Latest Data on Ultrasensitive ctDNA Assay for Residual Cancer and Recurrence Detection - Yahoo Finance

May 22, 2025
pulisher
May 22, 2025

New Clinical Data Reveals Groundbreaking Early Cancer Detection ResultsPersonalis ASCO Preview - Stock Titan

May 22, 2025
pulisher
May 19, 2025

Personalis Holds Virtual Annual Stockholders Meeting - TipRanks

May 19, 2025
pulisher
May 19, 2025

PSNL to Discuss Future Plans in Upcoming Virtual Meeting | PSNL Stock News - GuruFocus

May 19, 2025
pulisher
May 18, 2025

Brokerages Set Personalis, Inc. (NASDAQ:PSNL) PT at $8.00 - Defense World

May 18, 2025
pulisher
May 17, 2025

Personalis Inc (PSNL): A Sitting Duck With -162.63% Upside Potential - Stocksregister

May 17, 2025
pulisher
May 17, 2025

Guggenheim Begins Coverage on Personalis (NASDAQ:PSNL) - Defense World

May 17, 2025
pulisher
May 16, 2025

Personalis, Inc. (NASDAQ:PSNL) Stake Raised by Jane Street Group LLC - Defense World

May 16, 2025
pulisher
May 16, 2025

Jane Street Group LLC Has $2.32 Million Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - The AM Reporter

May 16, 2025
pulisher
May 16, 2025

Personalis, Inc. (NASDAQ:PSNL) Shares Acquired by Stifel Financial Corp - Defense World

May 16, 2025
pulisher
May 15, 2025

Guggenheim Initiates Buy Rating for Personalis (PSNL) with $6 Ta - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Guggenheim starts Personalis with a Buy, cites ‘best-in-class infrastructure’ - TipRanks

May 15, 2025
pulisher
May 15, 2025

Guggenheim Initiates Buy Rating for Personalis (PSNL) with $6 Target | PSNL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Guggenheim Initiates Personalis at Buy With $6 Price Target - marketscreener.com

May 15, 2025
pulisher
May 15, 2025

Guggenheim Starts Coverage on Personalis (PSNL) with Buy Rating - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Guggenheim Starts Coverage on Personalis (PSNL) with Buy Rating | PSNL Stock News - GuruFocus

May 15, 2025
pulisher
May 15, 2025

Dimensional Fund Advisors LP Purchases 242,141 Shares of Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 15, 2025
pulisher
May 15, 2025

Raymond James Financial Inc. Takes Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 15, 2025
pulisher
May 14, 2025

Leading Genomics Company Personalis Takes Center Stage at Major Craig-Hallum Investor Conference - Stock Titan

May 14, 2025
pulisher
May 12, 2025

Personalis stock price target raised to $9 at H.C. Wainwright By Investing.com - Investing.com Nigeria

May 12, 2025
pulisher
May 12, 2025

What is HC Wainwright’s Estimate for Personalis Q2 Earnings? - Defense World

May 12, 2025
pulisher
May 10, 2025

Personalis reiterates 2025 revenue guidance of $80M-$90M with focus on MRD testing growth - MSN

May 10, 2025
pulisher
May 09, 2025

HC Wainwright Raises Personalis (NASDAQ:PSNL) Price Target to $9.00 - Defense World

May 09, 2025
pulisher
May 09, 2025

Personalis (PSNL) Reports Q1 Loss, Tops Revenue Estimates - MSN

May 09, 2025
pulisher
May 08, 2025

Companies Like Personalis (NASDAQ:PSNL) Are In A Position To Invest In Growth - Yahoo Finance

May 08, 2025
pulisher
May 08, 2025

Barclays PLC Acquires 43,900 Shares of Personalis, Inc. (NASDAQ:PSNL) - The AM Reporter

May 08, 2025
pulisher
May 08, 2025

JPMorgan Chase & Co. Has $34,000 Position in Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 08, 2025
pulisher
May 08, 2025

Barclays PLC Increases Stock Holdings in Personalis, Inc. (NASDAQ:PSNL) - Defense World

May 08, 2025
pulisher
May 07, 2025

Personalis stock price target raised to $9 at H.C. Wainwright - Investing.com Australia

May 07, 2025
pulisher
May 07, 2025

Personalis Inc.: Strong Financial Performance and Promising Future Prospects Drive Buy Rating - TipRanks

May 07, 2025
pulisher
May 07, 2025

Will Personalis' Testing Growth And MRD Strategy Pay Off In 2025? - Nasdaq

May 07, 2025
pulisher
May 07, 2025

Analyst Expectations For Personalis's Future - Benzinga

May 07, 2025
pulisher
May 07, 2025

Personalis, Inc. (NASDAQ:PSNL) Q1 2025 Earnings Call Transcript - Insider Monkey

May 07, 2025
diagnostics_research DGX
$177.83
price up icon 0.43%
diagnostics_research WAT
$352.41
price down icon 0.70%
diagnostics_research LH
$260.59
price up icon 1.40%
$167.96
price down icon 0.12%
diagnostics_research MTD
$1,184.54
price down icon 0.73%
diagnostics_research IQV
$157.47
price down icon 0.44%
大文字化:     |  ボリューム (24 時間):